Souhaitez-vous accéder aux communiqués récents ?

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential market of $7B+ in the U.S. aloneMultiple milestones...

Fort Lauderdale, FL, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Anathapindika Health is a nutraceutical brand focused on supplements that detoxify overcrowded modern bodily systems and functions. Its...

Fort Lauderdale, FL, Jan. 07, 2026 (GLOBE NEWSWIRE) -- A new study from King’s College London and Maastricht University revealed that interesterified fats don’t have a clear harmful effect on...

ZUG, Switzerland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritisPrivosegtor is advancing...

Fort Lauderdale, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) -- A new study has shed light on how brain stem cells could play a crucial role in the growth of new brain cells. This could lead to longer...

Fort Lauderdale, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Anathapindika Health sells a trio of groundbreaking detoxification products. These are already popular overseas and are available in the US...

Fort Lauderdale, FL, Nov. 13, 2025 (GLOBE NEWSWIRE) -- November 5th was National Stress Awareness Day. The event is celebrated on the first Wednesday in November — right in time for the stressful...

SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation (GRF) today announced the 15th annual Glaucoma 360 event, which unites research, industry, and philanthropy to prevent...

Fort Lauderdale, FL, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The United States has the biggest health and wellness market in the world. As Anathapindika Health continues to expand its presence in the...

ZUG, Switzerland, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to...